|
KMID : 1155520130080040209
|
|
Anesthesia and Pain Medicine
2013 Volume.8 No. 4 p.209 ~ p.215
|
|
|
Diagnosis and management of postpartum hemorrhage
|
|
Park Sung-Wook
|
|
|
Abstract
|
|
|
|
Postpartum hemorrhage (PPH) is an important cause of maternal mortality. There is currently no single, satisfactory definition of PPH. The various definitions of PPH may result in delayed diagnosis. Underestimated blood loss concerning PPH is considered one of the biggest problems. The diagnosis of PPH should include proper estimation of blood loss before vital signs and clinical symptoms change. Management of PPH involves early recognition, assess-ment and resuscitation. Careful monitoring of vital signs, laboratory tests, coagulation testing in particular, and timely diagnosis of the cause of PPH are important. The first priority in the management of PPH is the rapid correction of hypovolemia with fluid infusion and packed red blood cells transfusion, followed by blood component therapy as indicated by the hematocrit, coagulation tests, platelet count and clinical features. Pharmacological manage-ment of PPH is to contract uterus (e.g., oxytocin, methylergonovine, 15-methylprostaglandin F2?, misoprostol) and to aid hemostasis (e.g., tranexamic acid, recombinant factor VIIa). Surgical manage-ment (e.g., balloon tamponade, uterine compression suture, iliac artery ligation) should be considered if hemorrhage persists or vital signs is unstable.
|
|
|
KEYWORD
|
|
|
Blood transfusion, Postpartum hemorrhage, Utero-tonics
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|
|